These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 22374861
1. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. Saccullo G, Malato A, Raso S, Santoro M, Zammit V, Casuccio A, Siragusa S. Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861 [Abstract] [Full Text] [Related]
3. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin. Malato A, Saccullo G, Lo Coco L, Caramazza D, Abbene I, Pizzo G, Casuccio A, Siragusa S. J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996 [Abstract] [Full Text] [Related]
4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P, Behounek J, Skoták M, Nevsímal L. Acta Chir Orthop Traumatol Cech; 2004 Jan; 71(4):237-44. PubMed ID: 15456102 [Abstract] [Full Text] [Related]
5. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AG, Bates SM, Desjardins L, Douketis J, Kahn SR, Solymoss S, Wells PS. Circulation; 2004 Sep 21; 110(12):1658-63. PubMed ID: 15364803 [Abstract] [Full Text] [Related]
10. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L, De Micheli V, Testa S, Frontoni R, Prisco D, Nante G, Iliceto S, Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies (FCSA). Circulation; 2009 Jun 09; 119(22):2920-7. PubMed ID: 19470892 [Abstract] [Full Text] [Related]
11. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM. Arch Intern Med; 2008 Jan 14; 168(1):63-9. PubMed ID: 18195197 [Abstract] [Full Text] [Related]
17. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Mismetti P, Mille D, Laporte S, Charlet V, Buchmüller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H, CIP Study Group. Haematologica; 2003 Jan 14; 88(1):67-73. PubMed ID: 12551829 [Abstract] [Full Text] [Related]